SCID mouse models of human stem cell engraftment

Stem Cells

Volumn 16, Issue 3, 1998, Pages 166-177

  Greiner, Dale L ^a   Hesselton, Ruth Ann ^a   Shultz, Leonard D ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Animal model; Differentiation; Hemopoiesis; Hu SRC SCID; Scid mouse; Scid repopulating cell (SRC); Stem cell

Indexed keywords

CELL DIFFERENTIATION; CELL SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; NONHUMAN; REVIEW; SCID MOUSE; STRAIN DIFFERENCE;

ANIMALIA; MURINAE;

EID: 0031805237     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.160166     Document Type: Review

References (120)

1. Peters SO, Kittler EL, Ramshaw HS et al. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 1995;23:461-469.
2. Peters SO, Kittler EL, Ramshaw HS et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11 and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996;87:30-37.
3. Quesenberry PJ. The blueness of stem cells. Exp Hematol 1991;19:725-728.
4. Harrison DE. Competitive repopulation: a new assay for long-term stem cell functional capacity in the mouse. Blood 1980;55:77-81.
5. McNiece IK, Stewart FM, Deacon DM et al. Detection of a human CFC with a high proliferative potential. Blood 1989;74:609-612.
6. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 1982;70:1324-1328.
7. Sutherland HJ, Eaves CJ, Eaves AC et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989;74:1563-1570.
8. Ploemacher R, Sloiys VDJ, Voermen J et al. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 1989;74:2755-2763.
9. Hao QL, Thiemann FT, Petersen D et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 1996;88:3306-3313.
10. Clutterbuck RD, Hills CA, Hoey P et al. Studies on the development of human acute myeloid leukaemia xenografts in immune-deprived mice: comparison with cells in short-term culture. Leuk Res 1985;9:1511-1518.
11. Ganick DJ, Sarnwick RD, Shahidi NT et al. Inability of intravenously injected monocellular suspensions of human bone marrow to establish in the nude mouse. Int Arch Allergy Appl Immunol 1980;62:330-333.
12. Urist MR, Grant TT, Lindholm TS et al. Induction of new-bone formation in the host bed by human bone-tumor transplants in athymic nude mice. J Bone Joint Surg 1979;61:1207-1216.
13. Watanabe S, Shimosato Y, Kameya T et al. Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole-body irradiation. Cancer Res 1978;38:3494-3498.
14. Zanjani ED, Almeida-Porada G, Flake AW. The human/sheep xenograft model: a large animal model of human hematopoiesis. Int J Hematol 1996;63:179-192.
15. Zanjani ED, Almeida-Porada G, Flake AW. Retention and multilineage expression of human hematopoietic stem cells in human-sheep chimeras. STEM CELLS 1995;13:101-111.
16. Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988;242:1706-1709.
17. Dick JE, Kamel-Reid S, Murdoch B et al. Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. Blood 1991;78:624-634.
18. Pollock PL, Germolec DR, Comment CE et al. Development of human lymphocyte-engrafted SCID mice as a model for immunotoxicity assessment. Fund Appl Toxicol 1994;22:130-138.
19. Ferrari G, Rossini S, Nobili N et al. Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions. Blood 1992;80:1120-1124.
20. Mombaerts P, Iacomini J, Johnson RS et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992;68:869-877.
21. Shinkai Y, Rathbun G, Lam KP et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992;68:855-867.
22. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527-530.
23. Martin A, Valentine M, Unger P et al. Engraftment of human lymphocytes and thyroid tissue into scid and rag2-deficient mice: absent progression of lymphocytic infiltration. J Clin Endo Metabol 1994;79:716-723.
24. Mosier DE, Gulizia RJ, Baird SM et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-259.
25. McCune JM, Namikawa R, Kaneshima H et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-1639.
26. Lapidot T, Pflumio F, Doedens M et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992;255:1137-1141.
27. Anonymous. Mouse genome database (MGD), mouse genome informatics project, The Jackson Laboratory, Bar Harbor, Maine. World Wide Web (URL:http://www.informatics.jax.org). 1996 (Unpublished).
28. Kirchgessner CU, Patil CK, Evans JW et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 1995;267:1178-1183.
29. Blunt T, Gell D, Fox M et al. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci USA 1996;93:10285-10290.
30. Fried LM, Koumenis C, Peterson SR et al. The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and P53 induction. Proc Natl Acad Sci USA 1996;93:13825-13830.
31. Jeggo PA, Jackson SP, Taccioli GE. Identification of the catalytic subunit of DNA dependent protein kinase as the product of the mouse scid gene. Curr Top Microbiol Immunol 1996;217:79-89.
32. Miller RD, Hogg J, Ozaki JH et al. Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proc Natl Acad Sci USA 1995;92:10792-10795.
33. Araki R, Fujimori A, Hamatani K et al. Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci USA 1997;94:2438-2443.
34. Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterization, and potential uses. Ann Rev Immunol 1991;9:323-350.
35. Lieber MR, Hesse JE, Lewis S et al. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 1988;55:7-16.
36. Malynn BA, Blackwell TK, Fulop GM et al. The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 1988;54:453-460.
37. Taylor PC. The Use of SCID Mice in the Investigation of Human Autoimmune Diseases. Austin, TX: R.G. Landes Company, 1994.
38. Nonoyama S, Smith FO, Bernstein ID et al. Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 1993;150:3817-3824.
39. Shultz LD, Schweitzer PA, Christianson SW et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995;154:180-191.
40. Bosma GC, Fried M, Custer RP et al. Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med 1988;167:1016-1033.
41. Lubin I, Faktorowich Y, Lapidot T et al. Engraftment and development of human T and B cells in mice after bone marrow transplantation. Science 1991;252:427-431.
42. Fraser CC, Kaneshima H, Hansteen G et al. Human allogeneic stem cell maintenance and differentiation in a longterm multilineage SCID-hu graft. Blood 1995;86:1680-1693.
43. - subpopulation from mobilized peripheral blood. Blood 1995;85:368-378.
44. Kaneshima H, Namikawa R, McCune JM. Human hematolymphoid cells in SCID mice. Curr Opinion Immunol 1994;6:327-333.
45. Kollmann TR, Kim A, Zhuang X et al. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. Proc Natl Acad Sci USA 1994;91:8032-8036.
46. Chen BP, Galy A, Kyoizumi S et al. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 1994;84:2497-2505.
47. Wagner JE, Collins D, Fuller S et al. Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 1995;86:512-523.
48. Heike Y, Ohira T, Takahashi M et al. Long-term human hematopoiesis in SCID-hu mice bearing transplanted fragments of adult bone and bone marrow cells. Blood 1995;86:524-530.
49. McCune JM. Development and applications of the SCID-hu mouse model. Semin Immunol 1996;8:187-196.
50. Uchida N, Combs J, Chen S et al. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 1996;88:1297-1305.
51. +bone marrow cells highly enriched for pluripotent stem cells. Exp Hematol 1996;24:936-943.
52. Muench MO, Roncarolo MG, Namikawa R. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood 1997;89:1364-1375.
53. Akkina RK, Rosenblatt JD, Campbell AG et al. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 1994;84:1393-1398.
54. Murray L, DiGiusto D, Chen B et al. Analysis of human hematopoietic stem cell populations. Blood Cells 1994;20:364-369; discussion 369.
55. Yurasov S, Kollmann TR, Kim A et al. Severe combined immunodeficiency mice engrafted with human T cells, B cells, and myeloid cells after transplantation with human fetal bone marrow or liver cells and implanted with human fetal thymus: a model for studying human gene therapy. Blood 1997;89:1800-1810.
56. DiGiusto DL, Lee R, Moon J et al. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. Blood 1996;87:1261-1271.
57. Urashima M, Chen BP, Chen S et al. The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood 1997;90:754-765.
58. + compartment of adult bone marrow. Blood 1995;85:2770-2778.
59. Roncarolo MG, Carballido JM, Rouleau M et al. Human T-and B-cell functions in SCID-hu mice. Semin Immunol 1996;8:207-213.
60. Rouleau M, Namikawa R, Antonenko S et al. Antigen-specific cytotoxic T cells mediate human fetal pancreas allograft rejection in SCID-hu mice. J Immunol 1996;157:5710-5720.
61. Jamieson BD, Aldrovandi GM, Zack JA. The SCID-hu mouse: an in vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. Semin Immunol 1996;8:215-221.
62. Rabin L, Hincenbergs M, Moreno MB et al. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother 1996;40:755-762.
63. Bonyhadi ML, Kaneshima H. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. Mol Med Today 1997;3:246-253.
64. Shimoni A, Marcus H, Canaan A et al. A model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: evidence for tumor-mediated suppression of antibody production in low-stage disease. Blood 1997;89:2210-2218.
65. Huppes W, Paulonis J, Dijk H et al. The role of natural antibodies and ABO (H) blood groups in transplantation of human lymphoid cells into mice. Eur J Immunol 1993;23:26-32.
66. Vormoor J, Lapidot T, Pflumio F et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994;83:2489-2497.
67. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-1337.
68. Cashman JD, Lapidot T, Wang JCY et al. Kinetic evidence of the regeneration of multi-lineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 1997;89:3919-3924.
69. Bhatia M, Wang JCY, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997;94:5320-5325.
70. Vormoor J, Lapidot T, Pflumio F et al. SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells 1994;20:316-320; discussion 320-322.
71. Sirard C, Lapidot T, Vormoor J et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 1996;87:1539-1548.
72. Terpstra W, Prins A, Ploemacher RE et al. Long-term leukemia-initiating capacity of a CD34 subpopulation of acute myeloid leukemia. Blood 1996;87:2187-2194.
73. Kamel-Reid S, Letarte M, Sirard C et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989;246:1597-1600.
74. Kamel-Reid S, Dick JE, Greaves A et al. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice. Leukemia 1992;6:8-17.
75. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-648.
76. Larochelle A, Vormoor J, Lapidot T et al. Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum Mol Genet 1995;4:163-172.
77. Bock TA, Orlic D, Dunbar CE et al. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 1995;182:2037-2043.
78. Cudkowicz G, Hochman PS. Do natural killer cells engage in regulated reactions against self to ensure homeostasis? Immunol Rev 1979;44:13-41.
79. Kiessling R, Hochman PS, Haller O et al. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977;7:655-663.
80. Yu YY, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Ann Rev Immunol 1992;10:189-213.
81. Barry TS, Jones DM, Richter CB et al. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens. J Exp Med 1991;173:167-180.
82. Shpitz B, Femandes BJ, Mullen JB et al. Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1. Anticancer Research 1994;14:1927-1934.
83. Shpitz B, Chambers CA, Singhal AB et al. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Meth 1994;169:1-15.
84. Lacerda JF, Ladanyi M, Jagiello C et al. Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17-scid/scid mice. Transplant 1996;61:492-497.
85. Sandhu J, Shpitz B, Gallinger S et al. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol 1994;152:3806-3813.
86. Hesselton RM, Greiner DL, Mordes JP et al. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Inf Dis 1995;172:974-982.
87. Vogel SN, Weinblatt AC, Rosenstreich DL. Inherent macrophage defects in mice. In: Gershwin ME, ed. Immunologic Defects in Laboratory Animals. New York: Plenum, 1981:327-382.
88. Christianson SW, Greiner DL, Schweitzer IB et al. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell Immunol 1996;171:186-199.
89. Wetsel RA, Fleisher DT, Haviland DL. Deficiency of the murine fifth complement component. J Biol Chem 1997;265:2435-2440.
90. Greiner DL, Shultz LD, Yates J et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 1995;146:888-902.
91. Kataoka S, Satoh J, Fujiya H et al. Immunologic aspects of the nonobese diabetic (NOD) mouse. Diabetes 1983;32:247-253.
92. Serreze DV, Leiter EH. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J Immunol 1988;140:3801-3807.
93. Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 1993;90:9625-9629.
94. Serreze DV, Gaskins HR, Leiter EH. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 1993;150:2534-2543.
95. Jacob CO, Aiso S, Michie SA et al. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin. Proc Natl Acad Sci USA 1990;87:968-972.
96. Baxter AG, Cooke A. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 1993;42:1574-1578.
97. Colten HR, Rosen FS. Complement deficiencies. Ann Rev Immunol 1992;10:809-834.
98. Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J Biol Chem 1990;265:2435-2440.
99. Bosma GC, Davisson MT, Ruetsch NR et al. The mouse mutation severe combined immune deficiency (scid) is on chromosome 16 [published erratum appears in Immunogenetics 1989;29:224]. Immunogenetics 1989;29:54-57.
100. Prochazka M, Gaskins HR, Shultz LD et al. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 1992;89:3290-3294.
101. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992;51:285-322.
102. Prochazka M, Gaskins HR, Leiter EH. Emv-30: a novel ecotropic MuLV present in NOD/Lt and NON/Lt strains. Mouse Genome 1991;89:280.
103. null NOD-scid mice. An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 1995;44:1392-1398.
104. Lowry PA, Shultz LD, Greiner DL et al. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice following irradiation or multiple day injections into unirradiated recipients. Biol Blood Marrow Transplant 1996;2:15-23.
105. Pflumio F, Izac B, Katz A et al. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 1996;88:3731-3740.
106. Wang JCY, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997;89:3919-3924.
107. +-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997;90:85-96.
108. Can OI, Murdoch B, Larochelle A et al. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 1997;90:641-650.
109. Bhatia M, Bonnet D, Kapp U et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997;186:619-624.
110. Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 1997;94:9836-9841.
111. Steele JPC, Clutterbuck RD, Powles RL et al. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice. Blood 1997;90:2015-2019.
112. Hendrickson EA, Qin XQ, Bump EA et al. A link between double-strand break-related repair and V(D)J recombination: the scid mutation. Proc Natl Acad Sci USA 1991;88:4061-4065.
113. Biedermann KA, Sun JR, Giaccia AJ et al. scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc Natl Acad Sci USA 1991;88:1394-1397.
114. Tanaka T, Yamagami T, Oka Y et al. The scid mutation in mice causes defects in the repair system for both double-strand DNA breaks and DNA cross-links. Mutat Res 1993;288:277-280.
115. Fulop GM, Phillips RA The scid mutation in mice causes a general defect in DNA repair. Nature 1990;347:479-482.
116. Disney JE, Barth AL, Shultz LD. Defective repair of radiation-induced chromosomal damage in scid/scid mice. Cytogenet Cell Genet 1992;59:39-44.
117. Zollner O, Lenter MC, Blanks JE et al. L-selectin from human, but not mouse neutrophils binds directly to E-selectin. J Cell Biol 1997;136:707-706.
118. + T cell engraftment in β2-microglobulin-deficient NOD-scid mice. J Immunol 1997;158:3578-3586.
119. Soderstrom I, Bergman ML, Colucci F et al. Establishment and characterization of RAG-2 deficient non-obese diabetic mice. Scand J Immunol 1996;43:525-530.
120. Archer DR, Turner CW, Yeager AM et al. Sustained multi-lineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood 1997;90:3222-3229.